hepatitis b surface antigen

The vaccine is intended for the prevention of hepatitis A and B in unvaccinated children (from 1 year of age), adolescents, and adults.

Form: suspension for injection

ATC: J07BC20

Manufacturer: GlaxoSmithKline Biologicals S.A. (formulation of vaccine, filling in syringe, quality control, labeling and packaging of finished product; batch release of finished product)